---
title: "Qianhong Bio-pharma conducted a block trade today at par, with 9.2 million shares traded and a transaction amount of 82.064 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245848706.md"
description: "On June 24th, Qianhong Bio-pharma had a block trade of 9.2 million shares, with a transaction amount of 82.064 million yuan, accounting for 7.73% of the total transaction amount for the day, and the transaction price was 8.92 yuan, which was flat compared to the market closing price of 8.92 yuan"
datetime: "2025-06-24T08:50:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245848706.md)
  - [en](https://longbridge.com/en/news/245848706.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245848706.md)
generator: "portal-rs"
---

# Qianhong Bio-pharma conducted a block trade today at par, with 9.2 million shares traded and a transaction amount of 82.064 million yuan

On June 24th, Qianhong Bio-pharma had a block trade of 9.2 million shares, with a transaction amount of 82.064 million yuan, accounting for 7.73% of the total transaction amount that day, at a transaction price of 8.92 yuan, which is flat compared to the market closing price of 8.92 yuan

### Related Stocks

- [002550.CN](https://longbridge.com/en/quote/002550.CN.md)

## Related News & Research

- [LibertyStream reports three months of battery-grade lithium carbonate output at 99.7%+ purity](https://longbridge.com/en/news/296788400.md)
- [Danantara Sumberdaya Indonesia is identifying commodity export inconsistencies, chief says](https://longbridge.com/en/news/296773364.md)
- [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md)
- [03:20 ETMacGregor advances direct ship-to-well LCO₂ transfer, built on 50 years of proven bow-loading technology](https://longbridge.com/en/news/296749870.md)
- [Exxaro Resources Non-GAAP EPS of R 13.77, revenue of R 22.1B; reaffirms FY 2026 outlook](https://longbridge.com/en/news/296457906.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**